Swedish Orphan Biovitrum AB (publ) (STO:SOBI)
277.00
-1.40 (-0.50%)
Sep 24, 2025, 5:29 PM CET
STO:SOBI Revenue
Swedish Orphan Biovitrum AB had revenue of 6.18B SEK in the quarter ending June 30, 2025, with 13.47% growth. This brings the company's revenue in the last twelve months to 26.97B, up 13.75% year-over-year. In the year 2024, Swedish Orphan Biovitrum AB had annual revenue of 26.03B with 17.65% growth.
Revenue (ttm)
26.97B
Revenue Growth
+13.75%
P/S Ratio
3.57
Revenue / Employee
13.92M
Employees
1,806
Market Cap
96.25B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 26.03B | 3.90B | 17.65% |
Dec 31, 2023 | 22.12B | 3.33B | 17.74% |
Dec 31, 2022 | 18.79B | 3.26B | 21.00% |
Dec 31, 2021 | 15.53B | 268.00M | 1.76% |
Dec 31, 2020 | 15.26B | 1.01B | 7.11% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sectra AB | 3.37B |
Getinge AB | 35.50B |
Camurus AB | 2.27B |
Medicover AB | 25.22B |
Asker Healthcare Group AB | 15.88B |
BioArctic AB | 1.86B |
AddLife AB | 10.44B |
Bonesupport Holding AB | 1.06B |
Swedish Orphan Biovitrum AB News
- 5 days ago - KalVista, Ionis/Sobi among latest to win EU nod for rare disease drugs - Seeking Alpha
- 5 days ago - Ionis Pharmaceuticals And Sobi Say EU Approves TRYNGOLZA For Familial Chylomicronemia Syndrome - Nasdaq
- 7 days ago - Swedish Orphan Biovitrum AB (Publ) (SWOBY) Discusses On NASP And Uncontrolled Gout Call (Transcript) - Seeking Alpha
- 8 days ago - Swedish Orphan Biovitrum AB (publ) - Special Call - Seeking Alpha
- 15 days ago - 10 stocks to consider if you want alternatives to the expensive S&P 500 - Market Watch
- 2 months ago - Swedish Orphan Biovitrum AB (publ) (BIOVF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Swedish Orphan Biovitrum AB (publ) 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 2 months ago - Swedish Orphan Biovitrum AB (BIOVF) Reports Strong Q2 Revenue Growth - GuruFocus